Medscape Conference Coverage, based on selected sessions at the:

EULAR 2008: The European League Against Rheumatism Annual Congress

June 11 - 14, 2008; Paris, France

This activity is not sanctioned by, nor a part of, the European League Against Rheumatism. Conference news does not receive grant support and is produced independently.

CME on This Topic

Expert Interviews

The ACR-EULAR Collaboration: An Expert Interview With David A. Fox, MD

David A. Fox, MD, President, ACR, provides expert commentary to Medscape on the new collaborative initiative between the ACR and EULAR.
An Expert Interview With Ferdinand C. Breedveld, MD, PhD

Ferdinand C. Breedveld, MD, PhD, President, EULAR, provides expert commentary to Medscape on the new collaborative initiative between the ACR and EULAR.

Video Commentaries

EULAR 2008 Highlights From Daniel Furst, MD

Daniel Furst, MD, gives his perspectives on key advances presented at EULAR 2008.
EULAR 2008 Highlights From Ronald F. van Vollenhoven, MD, PhD

Ronald F. van Vollenhoven, MD, PhD, gives his perspectives on some of the highlights at EULAR 2008.
EULAR 2008 Highlights From Maxime Dougados, MD

Maxime Dougados, MD, gives his perspectives on key advances presented at EULAR 2008, including the new initiative on the ACR-EULAR collaboration.

Conference News

Milnacipran Shows Promise for Fibromyalgia

In a phase 3 European study, the investigational agent milnacipran displayed activity against multiple symptoms of fibromyalgia.
Medscape Medical News, June 13, 2008
On Second Look, Belimumab Shows Activity Against SLE

A human monoclonal antibody has been shown to improve or stabilize disease activity in systemic lupus erythematosus.
Medscape Medical News, June 13, 2008
Knee Effusion on Ultrasound Predicts Joint Replacement in Osteoarthritis

Ultrasound effusion can be used as an independent predictor of the need for joint replacement.
Medscape Medical News, June 13, 2008

Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the European League Against Rheumatism. These materials and the related activity are not sanctioned by the European League Against Rheumatism or the commercial supporter of the conference and do not constitute an official part of that conference.